This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Original article
Chan, S. et al. An anti-PD1-GITR-L bispecific agonist induces GITR clustering-mediated T cell activation for cancer immunotherapy. Nat. Cancer https://doi.org/10.1038/s43018-022-00334-9 (2022)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Flemming, A. Bispecific agonist boosts anti-tumour T cells via GITR. Nat Rev Immunol 22, 208 (2022). https://doi.org/10.1038/s41577-022-00708-1
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41577-022-00708-1